(Note: This is a public offering of 2,608,695 ordinary shares with no par value, or ordinary shares, of Genenta S.p.A., which consists of (i) an initial public offering of 1,608,695 ordinary shares in the form of American Depositary Shares, or ADSs, each representing one of our ordinary shares, which we refer to as the “ADS […]

We are a producer of low carb, low calorie premium wines in the United States. Founded in 2019, our wines have rapidly gained visibility, credibility, and a loyal national customer base. We craft and bottle all of our wines in Napa Valley, which makes us a premier premium option in the rapidly growing “better for you” […]

We intend to focus our search on opportunities that contribute in positive ways towards energy transition and clean energy technology. (Incorporated in Bermuda)  This is an initial public offering of our securities. Each Stakeholder Aligned Initial Listing, or SAILSM security has an offering price of $10.00 and consists of one Class A share and one-half of one redeemable warrant. […]

We intend to concentrate on the high-growth Internet, media and adjacent industry segments, including online marketplaces, content and subscription management, education and training, advertising technology and direct-to-consumer businesses (collectively the “Internet & Digital Media Sector”) with initial enterprise valuations between $750.0 million and $2.0 billion. We intend to seek opportunities globally, with a particular emphasis on large […]

We intend to focus on the acquisition of a significant digital assets and cryptocurrency exchange, payment system and/or related financial services company, including wallets, lending and decentralized finance (“DeFi”). A significant number of cryptocurrency exchanges are located in Asia (such as Korea, Japan, Singapore and the Philippines), Europe, North America and Latin America. We will not […]

We intend to capitalize on the ability of our management team to identify, acquire and operate a business or businesses that can benefit from our management team’s established global relationships and operating experience. We believe the online real money gaming, technology, sports, digital media, hospitality and leisure industries possess attractive potential business combination targets that […]

We intend to focus our search on companies in the life sciences industry. We shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau). (Incorporated in the Cayman Islands) (Note: BioPlus Acquisition Corp. upsized its SPAC IPO at pricing on Dec. 2, 2021, […]

Intensity Therapeutics, Inc. is a clinical stage biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction leading to anti-cancer immune activation. Our new approach involves the direct injection into tumors of a unique product created from our DfuseRx℠ discovery platform.Our lead product candidate, INT230-6, consists of two proven anti-cancer cytotoxic agents, cisplatin […]

We intend to focus on a target business in the gaming and esports sectors. Concurrently with our initial business combination, we currently plan to merge with Gamers Club, a gaming technology subscription platform and community hub, based in Brazil and an affiliate of our sponsor, GEEX Sponsor, LLC. We will not, however, complete an initial […]

We intend to capitalize on the ability of our management team to identify, acquire and manage a business that can benefit from the unique operational, financial and investing acumen that members of our sponsor and management team have, particularly in gaming, but also across related areas within the broader digital media, creator economy, entertainment, and […]